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Abstract
Background: Several methanogenic archaea have been detected in the human intestinal microbiota. These intestinal
archaea may contaminate medical devices such as colonoscopes. However, no biocide activity has been reported among
these human-associated archaea.
Methodology: The minimal archaeacidal concentration (MAC) of peracetic acid, chlorhexidine, squalamine and twelve
parent synthetic derivatives reported in this study was determined against five human-associated methanogenic archaea
including Methanobrevibacter smithii, Methanobrevibacter oralis, Methanobrevibacter arboriphilicus, Methanosphaera
stadtmanae, Methanomassiliicoccus luminyensis and two environmental methanogens Methanobacterium beijingense and
Methanosaeta concilii by using a serial dilution technique in Hungates tubes.
Principal Findings: MAC of squalamine derivative S1 was 0.05 mg/L against M. smithii strains, M. oralis, M. arboriphilicus,
M. concilii and M. beijingense whereas MAC of squalamine and derivatives S2–S12 varied from 0.5 to 5 mg/L. For M.
stadtmanae and M. luminyensis, MAC of derivative S1 was 0.1 mg/L and varied from 1 to $10 mg/L for squalamine and its
parent derivatives S2–S12. Under the same experimental conditions, chlorhexidine and peracetic acid lead to a MAC of 0.2
and 1.5 mg/L, respectively against all tested archaea.
Conclusions/Significance: Squalamine derivative S1 exhibited a 10–200 higher archaeacidal activity than other tested
squalamine derivatives, on the majority of human-associated archaea. As previously reported and due to their week
corrosivity and their wide spectrum of antibacterial and antifungal properties, squalamine and more precisely derivative S1
appear as promising compounds to be further tested for the decontamination of medical devices contaminated by human-
associated archaea.
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Introduction
An increasing number of methanogenic archaea are being
found in the human microbiota [1]. Since Miller and collaborators
reported the isolation of methanogenic archaea Methanobrevibacter
smithii [2] from human feces, new strains were recently identified.
Thus, Methanosphaera stadtmanae [3] and Methanomassiliicoccus
luminyensis were isolated from human feces [4] and Methanobrevi-
bacter oralis was identified from the human subgingival plaque [5–
7]. Recently, we isolated Methanobrevibacter arboriphilicus [8] and
Methanobrevibacter millerae [9] from human feces specimens (S.
Khelaifia, M. Drancourt, unpublished data). Whereas M. smithii is
an almost constant inhabitant of the human gut [10], M. stadtmanae
was only found in about one-third of individuals [10] and M.
luminyensis in an average of 4% individuals with an age-dependent
prevalence [11]. It has been shown that purge used prior to
colonoscopy, may not eliminate these particular methanogenic
archaea: for instance, halophilic and methanogenic archaea M.
smithii, M. stadtmanae, M. arboriphilicus and Methanosaeta concilii [12]
were detected in colonic mucosal biopsies from patients who had
received a purge [13]. Therefore, these human-associated archaea
may contaminate any medical device soiled by feces such as
colonoscopes. This contamination could be problematic because
archaea significantly differ from bacteria so that the archaeacidal
activity of biocides cannot be simply deduced from their
bactericidal activity. Moreover, human-associated archaea have
been found to be highly resistant to most commonly used
antibiotics [14,15]. In the perspective of broadening the spectrum
of new active molecules, and more precisely against archaea
organisms colonizing the human gut, squalamine and its
derivatives appear to be among the few antimicrobial agents able
to demonstrate an efficient anti-archaea activity [14,15]. Squala-
mine is a natural aminosteol compound which is extracted from
the spiny dogfish shark live [16]. Among various properties, it was
found to be a potent antimicrobial compound active against both
Gram-positive and Gram-negative bacteria and fungi [17]. We
previously observed its in-vitro activity against four methanogenic
archaea [15]. Here, we investigated the in-vitro archaeacidal
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activity of 15 biocides including original squalamine derivatives
against seven archaea including five human-associated archaea.
Materials and Methods
Archaea
M. smithii ATCC 35061T DSMZ 861, M. smithii DSMZ 2374,
M. smithii DSMZ 2375, M. smithii DSMZ 11975, M. oralis DSMZ
7256 T, M. stadtmanae ATCC 43021T DSMZ 3091, Methanobacter-
ium beijingense [18] DSMZ 15999 and M. concilii DSMZ 2139,
purchased from the German Collection of Microorganisms and
Cell Cultures (DSMZ, Braunschweig, Germany). M. arboriphilicus
strain tested in this study was recently isolated in our laboratory
from human feces (S. Khelaifia, M. Drancourt, unpublished data).
M. smithii strains, M. arboriphilicus and M. beijingense were grown on
liquid media 119 (http://www.dsmz.de). The media 119 modified
by addition of 1 g of Yeast extract and 2.5-bar of H2/CO2 (80/20)
atmosphere was used to cultivate M. oralis. The media 322 (http://
www.dsmz.de) was used to cultivate M. stadtmanae and the media
334c (http://www.dsmz.de) to cultivate M. concilii, at 37uC in
Hungate tubes (Dutscher, Issy-les-Moulineaux, France) under a 2-
bar H2/CO2 (80/20) atmosphere under stirring. M. luminyensis
CSUR P135T was cultivated using Methanobrevibacter medium
(medium 119: http://www.dsmz.de) modified by the addition of
methanol and selenite/tungstate solution under 2-bar of H2/CO2
(80/20) atmosphere under stirring [4].
Biocides and Squalamine Derivatives
Chlorhexidine (MP Biomedicals, Illkirch, France) and peracetic
acid (ANIOS, Lille-Hellemmes, Fance) were tested in this study.
Concerning the synthesis of squalamine derivatives, all the solvents
were purified according to reported procedures and the reagents
used were commercially available. Methanol, ethyl acetate,
dichloromethane, ammonia and petroleum ether (35–60uC) were
purchased from Solvants Documentation Synthe`ses (Peypin,
France) and used without further purification. Column chroma-
tography was performed on silica gel (70–230 mesh). 1H NMR
and 13C NMR spectra were recorded in CDCl3 on a Bruker AC
300 spectrometer working at 300 MHz and 75 MHz, respectively
(the usual abbreviations are used: s: singlet, d: doublet, t: triplet, q:
quadruplet, m: multiplet). Tetramethylsilane was used as internal
standard. All chemical shifts are given in ppm. A mixture of the
desired ketosterol 1 or 2 (0.78 mmol), titanium (IV) isopropoxide
(302 mL, 1.03 mmol) and the desired amine (2.34 mmol) in
absolute methanol (5 mL) was stirred under argon at room
temperature for 12 hours. Sodium borohydride (29 mg,
0.78 mmol) was then added at 278uC and the resulting mixture
was stirred for an additional 2 hours. The reaction was then
quenched by adding water (1 mL) and stirring was maintained at
room temperature for 20 minutes. The resulting inorganic
precipitate was filtered off over a pad of Celite and washed with
Et2O and ethylacetate. The combined organic extracts were dried
over Na2SO4, filtered and concentrated in vacuo. The crude
product was placed in 10 mL of a MeOH/CHCl3 (1/1) solution,
128 mg of K2CO3 (0.93 mmol) were added and the mixture was
placed under stirring for 24 h. The solvents were evaporated and
the mixture was extracted with water and ethylacetate. The
combined organic extracts were dried over Na2SO4, filtered and
concentrated in vacuo. Subsequent purification by flash chroma-
tography on silicagel (eluent: CH2Cl2/MeOH/NH4OH(32%),
7:3:1) led to a pale yellow solid. All squalamine derivatives
reported here were prepared by using procedures similar to those
described above and all the NMR and MS analyses were in
accordance with the expected data.
Testing Archaeacidal Activity
A filtered aqueous solution of each one of the 12 biocides
(Figures 1, 2) was anaerobically added at a final 5 mg/L
concentration into Hungate tubes [19] containing distilled water;
tubes were previously sterilized by autoclaving at 120uC for
30 min under an H2/CO2 (80/20) atmosphere. The in-vitro
archaeacidal activity of the biocides was determined by transfer-
ring 10E+05 archaea cells/mL of an exponentially growing culture
into 4.5 mL of fresh medium containing 0.01, 0.05, 0.1, 0.2, 0.4,
0.8, 1, 5 or 10 mg/L of biocide. Tubes were incubated at 37uC
under stirring and archaea growth was observed after a 5-day
incubation. Cultures were centrifuged at 11,000 g for three
minutes at room temperature, washed with fresh medium to
remove traces of biocide and reinoculated into a new culture
medium. Control cultures without biocide were incubated in
parallel. Growth of archaea was assessed by optical microscopy
observation and parallel measurement of methane production
using a GC-8A gas chromatograph (Shimadzu, Champs-sur-
Marne, France) equipped with a thermal conductivity detector and
a Chromosorb WAW 80/100 mesh SP100 column (Alltech,
Carquefou, France). N2 at a pressure of 100 kPa was used as the
carrier gas. The detector and the injector temperature was 200uC
and the column temperature was 150uC. The in-vitro activity of
biocide under these culture conditions was verified as follows.
Culture media 119, 322, 334 (http://www.dsmz.de) and M. lumi-
nyensis medium were supplemented with a final concentration of
0.01, 0.05, 0.1, 0.2, 0.4, 0.8, 1, 5 or 10 mg/L of biocide and were
incubated at 37uC in a H2/CO2 (80/20) atmosphere for 10 days.
The activity of each biocide was controlled using clinical isolates of
Escherichia coli and Staphylococcus aureus [17,20] in the same culture
conditions as the tested archaea. Growth controls with appropriate
Figure 1. Structure of squalamine, chlorhexidine and peracetic acid.
doi:10.1371/journal.pone.0062738.g001
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media instead of derivative dilutions were introduced in all
experiments. The minimal archaeacidal concentration (MAC) was
defined as the lowest biocide concentration killing archaea
organisms. This was measured by observing the inhibition of
methane production and the absence of microscopically visible
growth of this archaea.
Results
The activity of the tested biocides incubated at 37uC under an
H2/CO2 (80/20) atmosphere was confirmed by observing the
killing of E. coli and S. aureus strains used as controls, after a 5-day
incubation. All the positive control cultures of M. smithii, M. oralis,
M. arboriphilicus, M. stadtmanae, M. luminyensis, M. beijingense and
M. concilii incubated without biocide grew as expected with a
methane production starting at day 3. As for four M. smithii strains,
M. oralis, M. arboriphilicus, M. concilii and M. beijingensis, MAC was of
0.05 mg/L for squalamine derivative S1; 0.5 mg/L for squala-
mine and derivatives S2–S6; and 2 to 5 mg/L for derivatives S7–
S12. As for M. stadtmanae and M. luminyensis, MAC was of 0.1 mg/
L for S1; 1 mg/L for squalamine and derivatives S2–S6; and
5 mg/L to $10 mg/L for derivatives S7–S12. Chlorhexidine and
peracetic acid lead to a MAC of 0.2 and 1.5 mg/L, respectively
against all tested archaea (Table 1).
Figure 2. Overview of the pathway for the synthesis of squalamine derivatives S1–S12.
doi:10.1371/journal.pone.0062738.g002
Table 1. Minimal archaeacidal concentration (MAC, mg/mL) of 15 biocides against archaea strains.
S1 S2 S3 S4 S5 S6 S7 S8 S9 S10 S11 S12 Squalamine Chlorhexidine
Peracetic
acid
M. smithii
ATCC35061T
0.05 0.5 0.5 0.5 0.5 0.5 5 5 5 5 5 2 0.5 0.2 1.5
M. smithii
DSMZ 2374
0.05 0.5 0.5 0.5 0.5 0.5 5 5 5 5 5 2 0.5 0.2 1.5
M. smithii
DSMZ 2375
0.05 0.5 0.5 0.5 0.5 0.5 5 5 5 5 5 2 0.5 0.2 1.5
M. smithii
DSMZ 11975
0.05 0.5 0.5 0.5 0.5 0.5 5 5 5 5 5 2 0.5 0.2 1.5
M. oralis
DSMZ 7256
0.05 0.5 0.5 0.5 0.5 0.5 5 5 5 5 5 2 0.5 0.2 1.5
M. arboriphilicus 0.05 0.5 0.5 0.5 0.5 0.5 5 5 5 5 5 2 0.5 0.2 1.5
M. beijingense
DSMZ 15999
0.05 0.5 0.5 0.5 0.5 0.5 5 5 5 5 5 2 0.5 0.2 1.5
M. consilii
DSMZ 2139
0.05 0.5 0.5 0.5 0.5 0.5 5 5 5 5 5 2 0.5 0.2 1.5
M. stadtmanae
ATCC 43021T
0,1 1 1 1 1 1 10 10 10 10 10 5 1 0.2 1.5
M. luminyensis
CSUR P13T
0.1 1 1 1 1 1 10 10 10 10 10 5 1 0.2 1.5
doi:10.1371/journal.pone.0062738.t001
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Discussion
Although several reports have documented the presence of
archaea in the human gut microbiota, they remain a neglected
field in medical microbiology. This is illustrated by the complete
lack of study addressing the archaeacidal activity of biocides. This
is surprising considering intestinal archaea can potentially
contaminate medical devices such as colonoscopes. Moreover, it
has been shown that a purge prior to colonoscopy does not
eliminate archaea from the gut [13]. Indeed, non-methanogenic
halophilic archaea have been detected in one purge preparation
[13]. Accordingly, transmission of methanogenic archaea between
patients via reusable medical equipments such as colonoscopes
may alter the intestinal microbiota, causing pathologies such as
digestive tract diseases and obesity [21,22]. Studying the
archaeacidal activity of some biocides is even more urgent, as
archaea exhibit a unique cell wall structure and composition which
keep the results from being simply extrapolated from what was
already known for bacteria. Accordingly, in general, archaea are
more resistant to antibiotics than bacteria [14,15].
Therefore, there was a need to assess the archaeacidal activity of
biocides used in routine. Here, since the controls introduced in all
experiments produced the expected results, the reported data have
been interpreted as authentic. In particular, we controlled the in-
vitro activity of molecules herein tested under the unusual
atmosphere comprising of 80% H2 and 20% CO2 required for
growing methanogenic archaea. In addition, we tested squalamine
as a positive control molecule and observed a MAC value in the
range of the previously reported value [17,20]. In the present
study, we extended data on squalamine to M. arboriphilicus, M.
beijingense and M. concilii which have not been previously tested for
their susceptibility to squalamine.
We observed that the susceptibility of archaea to biocides varies
depending on both the archaea species and the nature of the tested
biocide. In particular, M. stadmanae, an archaea found in almost
one-third of individuals [10], was twice more resistant to biocides
than the other tested archaea. This observation is in line with our
previous observation that M. stadmanae is more resistant to
antibiotics than M. smithii [14,15]. The mechanisms underlying
such differences are unknown but they should be broad-spectrum,
relatively poorly specific mechanisms such as differences in the cell
wall composition. Archaea possess membranes made of chemically
stable glycerol-ether lipid bonds. In some archaea the lipid bilayer
is replaced by a monolayer, in which the tails of two independent
phospholipid molecules are fused into a single molecule with two
polar heads [23]. This fusion may render membranes more rigid
and stable in harsh environments [24]. Archaea lipids are based
upon long isoprene side chain and often cyclopropane or
cyclohexane rings. These branched chains may keep archaeal
membranes from leaking at high temperatures or help them resist
to disrupting membrane agents [25,26]. Another broad-spectrum
mechanism relies on efflux of molecules. Whereas the M. smithii
ATCC 35061 complete genome (GenBank accession number
CP000678) encodes for six efflux pumps representing 3/1000 of
the genome size, M. stadtmanae DSM 3091 complete genome
sequence (GenBank accession number NC 007681) encodes for
four efflux pumps representing 4/1000 of the genome size.
Two commonly used biocides chlorhexidine and peracetic acid,
exhibited an archaeacidal activity under current decontamination
protocols and by using concentrations of 0.2 and 1.5 g/L,
respectively. However, squalamine and its derivatives exhibited a
higher activity than these two usual biocides on the majority of
here tested archaea, not on all archaea. Interestingly, these
compounds are equally active against Gram-negative and Gram-
positive bacteria, including bacteria from the human intestinal
microbiota [17,20]. They act directly on the cell membrane of the
bacteria by creating holes (Figure 3), emptying the cell cytoplasms
which lead to the death of the bacteria [17]. Data herein reported
indicate that some squalamine derivatives exhibited an increased
in-vitro activity against methanogenic archaea, particularly for
derivative S1. Indeed, the structure of the different squalamine
derivatives greatly influences their archaeacidal activity: aminos-
terol derivatives from dehydroepiandrosterone (DHEA) demon-
strate a lower activity (around 5 mg/mL) compared to pregnen-
olone derivatives (0.05 to 0.5 mg/mL) while they differ only by the
length of the side chain in position 17 suggesting a required
specific conformation by targeting archaea. On the other hand,
even in the same series the activity is conserved whatever the
nature of the amino side chain introduced except for derivative S1
which is ten times more active and which differs only by the
presence of three positive charges instead of two in all the other
products suggesting a potent interaction of the positive charge of
the compound with the negative charge of the archaeal membrane
(Figure 1). All these features constitute a basis for the development
of a new class of biocides devoted to the decontamination of
archaea-contaminated medical devices.
Figure 3. Images by electron microscopy demonstrating the morphological effects of squalamine on M. smithii cell wall. (A) M. smithii
without squalamine. (B) M. smithii +1 mg/L squalamine. White arrows show holes caused by squalamine on M. smithii cell wall. The scale bar
corresponds to 500 nm.
doi:10.1371/journal.pone.0062738.g003
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Conclusion
The data reported here indicate that peracetic acid, which is
routinely used for the desinfection of medical devices including
colonoscopes, is effective against human-associated archaea.
Nevertheless, less corrosive agents such as squalamine and its
parent derivatives appear as better promising biocides against the
majority of human-associated archaea. Studies are now under
current investigation to understand their involved mechanistic
rationale and improve their potent routinely use for disinfection of
medical devices including colonoscopes.
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